Mei Ri Jing Ji Xin Wen·2025-11-13 02:32Core Viewpoint - The trend of share buybacks among A-share listed companies is becoming more normalized, with many companies implementing multiple buyback plans within the year, indicating a strategic approach to maintaining market value [1][2][12]. Group 1: Buyback Plans and Execution - In October, 24 companies announced new buyback plans, with a total proposed buyback amount of approximately 6.65 billion yuan, a 67.55% increase from September's 3.969 billion yuan [2]. - Among the 24 companies, 13 planned to buy back over 100 million yuan, accounting for 54.17% of the total [2]. - Companies like Midea Group led the buyback efforts, with a single-month buyback exceeding 2 billion yuan for two consecutive months [1][7]. Group 2: Notable Companies and Their Strategies - Zhijiang Biology announced a buyback plan of 60 million to 120 million yuan, utilizing both self-funding and special loans, and has already initiated the buyback with a total payment of 2.0881 million yuan [3]. - Nine安医疗 has been actively maintaining its market value through buybacks, having completed five buyback plans since 2021, with a total payment of approximately 2.879 billion yuan [4][5]. - 中远海控 also launched a buyback plan of 749 million to 1.498 billion yuan, despite its stock price exceeding the buyback price limit, demonstrating confidence in its market value [6]. Group 3: Market Performance and Trends - The buyback execution rate was notably high in October, with 50% of the announced plans already initiated [4]. - Companies are increasingly using buybacks as a core method for market value management and shareholder returns, reflecting a more rational and mature approach to capital management [12]. - The overall market performance of companies like Zhijiang Biology has been positive, with a year-to-date increase of over 80% in stock price [3].